Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 May 3;14:62. doi: 10.1186/1471-2415-14-62

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 Kinori et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Visual acuity (VA) in LogMAR units in the control group (upper) and IV methylprednisolone treated group. Value above lines represents p-value of mean LogMAR VA compared to mean baseline VA at different time points. Baseline mean VA was the same in both groups: Log MAR 0.54 (equals to 20/70). The final VA was not statistically different form baseline in both groups: 0.43 (equals to 20/53) in the control group (p = 0.1 compared to baseline) and 0.61 (equals to 20/80) in the treated group (p = 0.8 compared to baseline). Note a very mild trend toward VA improvement in the control group versus worsening in the treated group, although statistically not significant.